학술논문
Cabozantinib in combination with atezolizumab in patients with metastatic castration-resistant prostate cancer: results from an expansion cohort of a multicentre, open-label, phase 1b trial (COSMIC-021)
Document Type
Article
Author
Agarwal, Neeraj ; McGregor, Bradley; Maughan, Benjamin L; Dorff, Tanya B; Kelly, William; Fang, Bruno; McKay, Rana R; Singh, Parminder; Pagliaro, Lance; Dreicer, Robert; Srinivas, Sandy; Loriot, Yohann; Vaishampayan, Ulka; Goel, Sanjay; Curran, Dominic; Panneerselvam, Ashok; Schwickart, Martin; Choueiri, Toni K ; Pal, Sumanta
Source
In The Lancet Oncology July 2022 23(7):899-909
Subject
Language
ISSN
1470-2045